The University of Washington recently hosted a panel of five entrepreneurs to discuss what it takes to launch a life sciences company. Panelists shared how they got a foothold in… Read More
Seattle biotech startup PvP Biologics, which developed a promising treatment for people who can’t digest gluten, was acquired by Japanese pharmaceutical Takeda for up to $330 million in late February.… Read More
When it was time for PvP Biologics to test its promising treatment for celiac disease, the Seattle startup wanted to keep things local. They needed a meal, something that would… Read More
Synthetic genomes and gene editing are big things today, but the next big things in biotechnology could be proteins that are designed and edited on computers – and are then synthesized… Read More